ABOUT US
Cytiva provides the expertise and tools spanning a wide range of applications from basic research of proteins and cells to large-scale purification of biopharmaceuticals. Within the bioprocessing space, Cytiva provides products and expertise for developers and manufacturers of biotherapeutics to enable efficient, flexible and cost-effective approaches to characterization, expression and purification of biomolecules. The company offers tools and support to take recombinant proteins, monoclonal antibodies, plasma proteins, oligonucleotides and vaccines from research, through process development, to full-scale manufacturing. Cytiva has a "healthymagination" vision for the future to improve quality, decrease costs and increase access to better healthcare around the world.
Bioprocessing: cell culture, chromatography and filtration solutions, and analytics
Cytiva's portfolio encompasses both upstream and downstream processing and includes solutions for large-scale production as well as tools for process development, Quality by Design, analytical analysis and flexible manufacturing. Some key product areas are listed below:
- ReadyToProcess™ - a platform of ready to use, and single use, flexible-manufacturing equipment, includes WAVE Bioreactor™ systems and Cellbag™ single-use cell culture bioreactors.
- Xcellerex™ - a single-use technologies platform including XDR bioreactors, XDM Quad Mixers, and related single-use assemblies
- PreDictor™ 96-well plates and PreDictor RoboColumn™ units for process development of chromatography separations
- ULTA™ filters for sterile filtration and clarification applications
- MabSelect SuRe™ LX, the Capto™ media family; and Capto ImpRes all modern BioProcess™ media for all phases of purification
- ÄKTA™ systems for all scales of chromatography and filtration
- AxiChrom™ chromatography columns
- Technical support, and training through Fast Trak services
Cytiva's products enable improvements in process efficiency through optimized performance, advanced automation, integrated unit operations, and technical support. These solutions allow agile manufacturing with shortened development times and excellent facility utilization. The company offers complete start-to-finish solutions in a range of areas such as monoclonal antibodies, plasma proteins, oligonucleotides and vaccines, and is continuously developing its range of products and services.
Additionally, Cytiva has a range of products for characterization and analysis of biomolecular interactions and biomolecule stability, including Biacore™ SPR and MicroCal™ DSC systems.
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED ARTICLES
- Public Sector Forged, Private Sector Tested With Renovaro BioSciences' Mark Dybul, M.D.
- Welcoming The “Era Of ADCs”
- mRNA Vaccine Platforms With Combined Therapeutics' Dr. Romain Micol
- Biotech Dealmaking With Regeneron's Nouhad Husseini
- Backpacks And Biotech With Luke Timmerman
- Bioreactor Scaling Made Simpler
- RNA Delivery Business With Liberate's Shawn Davis, Ph.D. & Walter Strapps, Ph.D.
- In Silico Approaches Towards Automated Biomanufacturing
- Bioprocessing 4.0: Digital Transformation Of Biopharmaceutical Process Development
- Simulation Gets Therapies To Patients Faster And Smarter
- The Legend Steve Gorlin's Golden Rules
- CDMO + Emerging Bio Partnership With Forge's John Maslowski And Ray's Jenny Holt
- Clinical Leadership with Cue Biopharma's Anish Suri, Ph.D. & Dan Passeri, J.D.
- Bio Career Moves With Codagenix's Johanna Kaufmann, Ph.D.
- In Silico Optimization Of A Multimodal Chromatography mAb Polishing Step
- Veteran Advice From The C-Suite With Citius' Leonard Mazur
- Don't Be A D**k With Ochre Bio's Dr. Quin Wills
- Developing A HIC Polishing Step For The Removal Of mAb Aggregates
- Pragmatic Computational Biology With Andrew Satz
- Commercial Readiness With Orca Bio's Dan Kirby
- Continuous Processing For Enhanced Monoclonal Antibody Production
- Bio & The Business Of Aging With Life Biosciences' Jerry McLaughlin
- Biopharma Manufacturing For Advanced Therapies: A Panel Discussion
- Enhancing Security Of Supply Of Cell Culture Media With Single-Use Bags
- Sterile Filtration And Quality Risk Management
- Fiscal Turnarounds With Protalix's Eyal Rubin
- Building LEO Pharma's U.S. Presence With Brian Hilberdink
- Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD
- Facing NASH Therapeutic Skepticism With 89bio's Rohan Palekar
- Biotech Cash Management With Allan Shaw
- Establishing Research With Horizon Therapeutics' Robert Stoffel, Ph.D.
- Outsourcing: Biomanufacturers May Need Consultants More Than Ever
- Oligonucleotide Manufacturing: How To Get A Strong Start
- Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard
- COO Liftoff With Rocket Pharmaceuticals' Kinnari Patel, PharmD
- The Colloidal Particle Adsorption (CPA) Model In IEX
- Alkaline Stability Of Modern Protein A Chromatography Resins
- Protein L Affinity Resin Is Ready To Move To Manufacturing
- Improving Efficiency In Upstream Process Development
- ML-Enabled Drug Discovery With LabGenius' James Field, Ph.D.
- Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD
- Origins Of A Biopharma VC Deal With Bernat Olle, Ph.D. And Parag Shah
- Population-Level Health Impact With Vaxxinity's John Krayacich
- The Face Of African Biotech With Adrienne Leussa, Ph.D.
- The Innovation Reduction Act With Allan Shaw
- Propagating Peptides With Peptilogics' Jonathan Steckbeck, Ph.D.
- Resilient Biopharma Leadership With Ambrx's Dan O'Connor
- Funding A Neurodegeneration Startup With Coya Therapeutics' Howard Berman
- A More NIIMBL Biotech Workforce With John Balchunas
- AAV Full/Empty Capsid Separation Using Mechanistic Modeling
- Recombinant Protein Purification Optimization With HIC
- Alkaline Stability Of Fc And VH3 Binding In Protein A Resins
- How To Develop An Efficient Downstream Purification Process For bsAbs
- Building Flagship Pioneering With Avak Kahvejian, Ph.D.
- Therapeutic Molecules From Moss With Drs. Andreas Schaaf And Björn Cochlovius
- Gene Tx For Hearing Loss With Sensorion's Nawal Ouzren
- How To Best Optimize mRNA Production Workflows
- Controlling Trace Impurities In Chemically Defined Media
- Functional Ectopic Organs With LyGenesis' Michael Hufford, Ph.D.
- Approvals & Mergers: Inside Enzyvant With Bill Symonds, Pharm.D.
- Next-Gen Nanobodies With MoonLake's Jorge Santos Da Silva, Ph.D.
- Lessons From The Bone Therapeutics/Medsenic Merger
- TCRs In Personalized Oncology With BlueSphere Bio's Keir Loiacono
- BoB@JPM: Self-Replicating RNA With Elixirgen's Akihiro Ko
- BoB@JPM: Gene Writing With Tessera's Michael Severino, M.D.
- Challenges Of The IVT Reaction In mRNA Production
- How To Maintain A Nuclease Free Environment During mRNA Production
- How To Choose A Capping Method In MRNA Production
- BoB@JPM: Post-IPO With Bolt Bio Drs. Randall Schatzman and Edith Perez
- Simplifying Bioprocess Data Collection
- Key Components And Functions Of The ÄKTA oligosynt™ Synthesizer
- Small-Scale Oligonucleotide Synthesizer That Supports Scale Up
- LNP Formulation For mRNA delivery
- mRNA Product Purification Process Strategies
- mRNA Product IVT Process Insights
- mRNA: Challenges And Strategies Related To The DNA Template Process
- Introduction To mRNA Manufacturing
- BoB@JPM: Academia To Industry With Oncolytics' Matt Coffey, Ph.D.
- A Guide To Polishing Chromatography In Process Development
- BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.
- Using Mathematical Models To Improve Process Development
- Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.
- Understanding The Oligonucleotide Synthesis Process
- Biopharma Resilience: Addressing Manufacturing And Talent Needs
- Biopharma Resilience: Building Biomanufacturing Capacity
- How Distributed Automation And DPM Support Resilient Biomanufacturing
- Modality-Agnostic Drug Discovery With Cullinan Oncology's Nadim Ahmed
- Women In Biotech With Bill & Melinda Gates MRI's Piper Trelstad, Ph.D.
- rAAV Production Using HEK293 Cell Line And Transfection Medium
- Establishing A Robust Workflow To Identify High-Performing Clones
- Computational Drug Discovery With Gain Therapeutics' Matthias Alder
- Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany
- AI & Computational Biology With Recursion's Chris Gibson, Ph.D.
- Financing Biopharma Innovation With Allan Shaw
- Gene Therapy For Chronic Inflammation With Xalud's Howard Rutman, M.D.
- Pursuing A “Biologic Revolution” With Vaxxinity’s Mei Mei Hu
- The Antibody Engine With Abpro's Chan Brothers
- Longhorn’s Path To A Universal Influenza Vaccine
- Epigenomic Programming With Omega Therapeutics’ Mahesh Karande
- In-Vivo CAR T Update With Umoja Biopharma's David Fontana, Ph.D.
- RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati
- Capture Of Bispecific Antibodies And Removal Of Product-Related Impurities
- Generating A Robust Host Cell Line For A Cell Line Development Platform
- Making Medicine From Tick Spit: Akari Therapeutics' Rachelle Jacques
- The Road To Reality For Allogeneic Cell Therapy
- Product Vs. Platform With Surface's Vito Palombella, Ph.D. And Robert Ross, M.D.
- Leveraging Lymph Nodes With Elicio's Dr. Peter DeMuth
- How Biopharma Can Address Specialized Skills Gaps And Improve Resilience
- Engineering Proteins For Food Allergies With Ukko's Dr. Anat Binur
- Saudi Arabia Government Leaders Discuss Agile Manufacturing Beyond Borders
- Addressing Rapid Biomanufacturing Capacity Needs
- Biopharma Resilience: CDMOs Secure Supply Chain Management
- 5 Translational Research Challenges On The Path To Patients
- Anatomy Of A VC Deal With Dima Kuzmin & Paul Bresge
- Oncology Discovery Advances With AbbVie's Steve Davidsen, Ph.D.
- Investments, Capacity Expansion, And Improvements
- Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility
- IND For TIL Therapy With Obsidian Therapeutics' Paul Wotton, Ph.D.
- Dry Powdered Medium Milling Equivalency Study
- Origin Equivalence Study: HyClone Characterized Fetal Bovine Serum (FBS)
- What Makes A High-Quality Chromatography Resin?
- Regenerative Wound Care With BioStem Technologies
- From Discovery To Commercial Promise With Philogen’s Dr. Dario Neri
- Epigenomic Programming With Omega Therapeutics' Mahesh Karande
- IDO Target Perseverence With IO Biotech's Mai-Britt Zocca, Ph.D.
- Pursuit Of A Universal Flu Vaccine With Longhorn Vaccines & Diagnostics' Jeff Fischer
- Genetic Testing & Neurodegenerative Disorders With AviadoBio's Lisa Deschamps
- Biotech M&A Anomalies With Allan Shaw
- Rethinking Cancer Treatment With Anixa’s Amit Kumar
- Gene Therapies For Better Kidney Treatments With Purespring Therapeutics
- Observations On Outsourcing With Molecule To Market's Raman Sehgal
- Pursuing Growth Strategies And Aggressive Advocacy
- Pursuing Venture Philanthropy With Opus Genetics: The Business Of Biotech
- Pursuing Hybrid Funding Models With Silence Therapeutics’ Craig Tooman
- What's A Biologic Revolution? With Vaxxinity's Mei Mei Hu, J.D.
- Fed Funding: Creative Capital Generation With James Thomas Coates, Ph.D.
- Oligonucleotide Opportunities In DMD With PepGen's James McArthur, Ph.D.
- Surface Plasmon Resonance (SPR): Visualize Your Research
- Biotin CAPture Kit Ready-To-Go Interaction Analysis
- Outstanding Sensitivity For Confident SPR Interaction Analysis
- Explore Protein Interactions Beyond Affinity To Boost Your Academic Research
- The Critical Role Of CDMOs In Driving Biomanufacturing Resilience
- Diabetes: Changing The Insulin Paradigm
- Cytiva Expanding US Operations
- Innate Immunity & Mouse Models With LIfT Biosciences' Alex Blyth
- Antibody Cocktails With Immunome's Dr. Purnanand Sarma
- Antibody-Cytokine Combinations With Philogen's Dr. Dario Neri
- Simplify Bioreactor Scale Up And Scale Down
- Fibroblasts In Regenerative Medicine With Pete O'Heeron & Dr. Hamid Khoja
- mRNA Manufacturing: Overcoming CMC Development Challenges
This website uses cookies to ensure you get the best experience on our website. Learn more